[Federal Register Volume 65, Number 33 (Thursday, February 17, 2000)]
[Notices]
[Pages 8180-8181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3806]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Gastrointestinal Drugs Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

    Name of Committee: Gastrointestinal Drugs Advisory Committee.

[[Page 8181]]

    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 12, 2000, 8 
a.m. to 5 p.m.
    Location: Hilton, Grand Ballroom, 620 Perry Pkwy., Gaithersburg, 
MD.
    Contact Person: Karen M. Templeton-Somers, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12538. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The committee will discuss current information on the 
safety of Janssen Pharmaceutica's Propulsid (cisapride) 
and methods to reduce the occurrence of adverse events associated 
with its use.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 3, 
2000. Oral presentations from the public will be scheduled between 
approximately 8:15 a.m. and 9:15 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before April 3, 2000, 
and submit a brief statement of the general nature of the evidence 
or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation. After the scientific 
presentations, a 30-minute open public session may be conducted for 
interested persons who have submitted their request to speak by 
April 3, 2000, to address issues specific to the submission or topic 
before the committee.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 9, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-3806 Filed 2-16-00; 8:45 am]
BILLING CODE 4160-01-F